Bäckbro K, Löwgren S, Osterlund K, Atepo J, Unge T, Hultén J, Bonham N M, Schaal W, Karlén A, Hallberg A
Department of Molecular Biology, Uppsala University, Sweden.
J Med Chem. 1997 Mar 14;40(6):898-902. doi: 10.1021/jm960588d.
Two cyclic, C2-symmetric HIV-1 protease inhibitors, one sulfamide and one urea derivative, both comprising phenyl ether groups in the P1/P1' positions, were cocrystallized with HIV-1 protease, and the crystal structures were determined to 2.0 A resolution. The structure of the urea 2 showed a conformation similar to that reported for the related urea 3 by Lam et al., while the sulfamide 1 adopted an unanticipated conformation in which the P1' and P2' side chains were transposed.
两种环状的、具有C2对称性的HIV-1蛋白酶抑制剂,一种是磺酰胺类,一种是尿素衍生物,二者在P1/P1'位置均含有苯醚基团,它们与HIV-1蛋白酶共结晶,并测定了分辨率为2.0 Å的晶体结构。尿素2的结构显示出与Lam等人报道的相关尿素3相似的构象,而磺酰胺1则呈现出一种意想不到的构象,其中P1'和P2'侧链发生了互换。